NYU Langone Health: Lung Neoplasms trials

The registry lists 10 Lung Neoplasms studies with NYU Langone Health as lead sponsor. 2 are open to participants now and 3 have results posted.

Early Phase 1 1Phase 1 2Phase 2 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung CancerRecruitingNCT04063501
• Lung Cancer Biomarkers and ScreeningRecruitingNCT00301119
• Bronchoscopic Cryo-Immunotherapy of Lung CancerCompletedNCT04049474Early Phase 1Results posted
• Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)TerminatedNCT02934503Phase 2Results posted
• Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT02221739Phase 1/2Results posted
• Ladarixin With Sotorasib in Advanced NSCLC - Phase IIWithdrawnNCT05815186Phase 2
• Female Asian Nonsmoker Screening StudyActive, not recruitingNCT05164757
• Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung CancerCompletedNCT00012103Not applicable
• Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who SmokeCompletedNCT00005883Phase 1
• R115777 in Treating Patients With Relapsed Small Cell Lung CancerCompletedNCT00005041Phase 2